ASCEND's mission is to research and develop transdermal therapies that utilize the company's proprietary percutaneous hydroalcoholic gel technology to deliver therapy in instances where oral delivery is impossible or undesirable. Currently, ASCEND's research efforts are focused in the areas of women's breast health and men's health.
To learn more about ASCEND's research projects, visit the website of our R&D affiliate BHR Pharma, LLC.